POLYCYSTIC OVARY SYNDROME
Clinical trials for POLYCYSTIC OVARY SYNDROME explained in plain language.
Never miss a new study
Get alerted when new POLYCYSTIC OVARY SYNDROME trials appear
Sign up with your email to follow new studies for POLYCYSTIC OVARY SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug hope for fatty liver in PCOS women?
Disease control TerminatedThis study tested a drug called saroglitazar in women with polycystic ovary syndrome (PCOS) who also have nonalcoholic fatty liver disease (NAFLD). The goal was to see if the drug could safely reduce liver fat over 24 weeks compared to a placebo. The trial was planned for 60 wome…
Matched conditions: POLYCYSTIC OVARY SYNDROME
Phase: PHASE2 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
PCOS drug trial halted early: did tildacerfont lower hormones?
Disease control TerminatedThis study tested a drug called tildacerfont in 27 women with polycystic ovary syndrome (PCOS) who had high levels of adrenal androgens (hormones). The goal was to see if the drug could safely lower these hormones. The trial was stopped early, so results are limited.
Matched conditions: POLYCYSTIC OVARY SYNDROME
Phase: PHASE2 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC